
USD
+$0.00
(+0.00%
)At Close (As of Dec 3, 2025)
$26.93B
Market Cap
149.05
P/E Ratio
0.19
EPS
$29.54
52 Week High
$20.65
52 Week Low
HEALTHCARE
Sector
| Field | Value (EUR) |
|---|---|
| Gross Profit | $7.8B |
| Total Revenue | $18B |
| Cost Of Revenue | $10B |
| Costof Goods And Services Sold | $10B |
| Operating Income | $529M |
| Selling General And Administrative | $582M |
| Research And Development | $1.7B |
| Operating Expenses | $7.2B |
| Investment Income Net | - |
| Net Interest Income | -$257M |
| Interest Income | $79M |
| Interest Expense | $337M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $1.4B |
| Income Before Tax | $123M |
| Income Tax Expense | $963M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$840M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $460M |
| Ebitda | $1.8B |
| Net Income | -$702M |
| Field | Value (EUR) |
|---|---|
| Total Assets | $29B |
| Total Current Assets | $10B |
| Cash And Cash Equivalents At Carrying Value | $2.4B |
| Cash And Short Term Investments | $2.4B |
| Inventory | $3.2B |
| Current Net Receivables | $3.7B |
| Total Non Current Assets | $19B |
| Property Plant Equipment | $2.5B |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $3B |
| Intangible Assets Excluding Goodwill | $3B |
| Goodwill | $10B |
| Investments | - |
| Long Term Investments | $889M |
| Short Term Investments | $2M |
| Other Current Assets | $749M |
| Other Non Current Assets | - |
| Total Liabilities | $17B |
| Total Current Liabilities | $8.1B |
| Current Accounts Payable | $1.8B |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $443M |
| Total Non Current Liabilities | $8.8B |
| Capital Lease Obligations | $1.1B |
| Long Term Debt | $6.2B |
| Current Long Term Debt | $224M |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $7.5B |
| Other Current Liabilities | $4B |
| Other Non Current Liabilities | $44M |
| Total Shareholder Equity | $12B |
| Treasury Stock | - |
| Retained Earnings | $3.7B |
| Common Stock | $188M |
| Common Stock Shares Outstanding | $933M |
| Field | Value (EUR) |
|---|---|
| Operating Cashflow | $1.7B |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $1.3B |
| Capital Expenditures | $343M |
| Change In Receivables | - |
| Change In Inventory | $249M |
| Profit Loss | - |
| Cashflow From Investment | -$634M |
| Cashflow From Financing | -$537M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | $1.1M |
| Dividend Payout Common Stock | $1.1M |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | -$445M |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$913M |
| Field | Value (EUR) |
|---|---|
| Gross Profit | $7.8B |
| Total Revenue | $18B |
| Cost Of Revenue | $10B |
| Costof Goods And Services Sold | $10B |
| Operating Income | $529M |
| Selling General And Administrative | $582M |
| Research And Development | $1.7B |
| Operating Expenses | $7.2B |
| Investment Income Net | - |
| Net Interest Income | -$257M |
| Interest Income | $79M |
| Interest Expense | $337M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $1.4B |
| Income Before Tax | $123M |
| Income Tax Expense | $963M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$840M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $460M |
| Ebitda | $1.8B |
| Net Income | -$702M |
| Field | Value |
|---|---|
| Ex Dividend Date | 2025-05-13 |
| Declaration Date | 2025-02-19 |
| Record Date | 2025-05-13 |
| Payment Date | 2025-06-06 |
| Amount | 0.88604 |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Koninklijke Philips NV (PHG) is a leading global healthcare technology company headquartered in Amsterdam, Netherlands, focused on improving health outcomes across the healthcare continuum. With a strong portfolio encompassing diagnostic imaging, patient monitoring, and personal health solutions, Philips maintains a significant market presence especially in North America and Greater China. The company leverages cutting-edge technology and digital health platforms to enhance care quality and operational efficiencies, while emphasizing sustainability in its operations. As a key player in the rapidly evolving health technology landscape, Philips is strategically positioned to meet the rising demands of healthcare providers globally.